Literature DB >> 22975381

A "twist box" code of p53 inactivation: twist box: p53 interaction promotes p53 degradation.

Sara Piccinin1, Elena Tonin, Sara Sessa, Silvia Demontis, Sabrina Rossi, Lorenza Pecciarini, Lucia Zanatta, Flavia Pivetta, Alessandra Grizzo, Maura Sonego, Camillo Rosano, Angelo Paolo Dei Tos, Claudio Doglioni, Roberta Maestro.   

Abstract

Twist proteins have been shown to contribute to cancer development and progression by impinging on different regulatory pathways, but their mechanism of action is poorly defined. By investigating the role of Twist in sarcomas, we found that Twist1 acts as a mechanism alternative to TP53 mutation and MDM2 overexpression to inactivate p53 in mesenchymal tumors. We provide evidence that Twist1 binds p53 C terminus through the Twist box. This interaction hinders key posttranslational modifications of p53 and facilitates its MDM2-mediated degradation. Our study suggests the existence of a Twist box code of p53 inactivation and provides the proof of principle that targeting the Twist box:p53 interaction might offer additional avenues for cancer treatment.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22975381     DOI: 10.1016/j.ccr.2012.08.003

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  62 in total

1.  N-terminal truncations of human bHLH transcription factor Twist1 leads to the formation of aggresomes.

Authors:  Gokulapriya Govindarajalu; Murugan Selvam; Elango Palchamy; Sudhakar Baluchamy
Journal:  Mol Cell Biochem       Date:  2017-08-04       Impact factor: 3.396

2.  FOXD3 modulates migration through direct transcriptional repression of TWIST1 in melanoma.

Authors:  Michele B Weiss; Ethan V Abel; Neda Dadpey; Andrew E Aplin
Journal:  Mol Cancer Res       Date:  2014-07-24       Impact factor: 5.852

Review 3.  Regulation of the protein stability of EMT transcription factors.

Authors:  V M Díaz; R Viñas-Castells; A García de Herreros
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

Review 4.  Inflammation fuels tumor progress and metastasis.

Authors:  Jingyi Liu; Pengnian Charles Lin; Binhua P Zhou
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

5.  In silico prediction of physical protein interactions and characterization of interactome orphans.

Authors:  Max Kotlyar; Chiara Pastrello; Flavia Pivetta; Alessandra Lo Sardo; Christian Cumbaa; Han Li; Taline Naranian; Yun Niu; Zhiyong Ding; Fatemeh Vafaee; Fiona Broackes-Carter; Julia Petschnigg; Gordon B Mills; Andrea Jurisicova; Igor Stagljar; Roberta Maestro; Igor Jurisica
Journal:  Nat Methods       Date:  2014-11-17       Impact factor: 28.547

6.  2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol reverses EGF-induced cell migration and invasion through down-regulation of MDM2 in breast cancer cell lines.

Authors:  Dayong Zheng; Xing Chang; Yang Liu; Jingwen Xu; Wenfeng Gou; Zengqiang Li; Daiying Zuo; Weige Zhang; Yingliang Wu
Journal:  Cancer Biol Ther       Date:  2018-12-04       Impact factor: 4.742

7.  Inhibition of Twist1-mediated invasion by Chk2 promotes premature senescence in p53-defective cancer cells.

Authors:  Debasis Nayak; Anmol Kumar; Souneek Chakraborty; Reyaz Ur Rasool; Hina Amin; Archana Katoch; Veena Gopinath; Vidushi Mahajan; Mahesh K Zilla; Bilal Rah; Sumit G Gandhi; Asif Ali; Lekha Dinesh Kumar; Anindya Goswami
Journal:  Cell Death Differ       Date:  2017-05-12       Impact factor: 15.828

Review 8.  Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases.

Authors:  Vladimir N Uversky; Vrushank Davé; Lilia M Iakoucheva; Prerna Malaney; Steven J Metallo; Ravi Ramesh Pathak; Andreas C Joerger
Journal:  Chem Rev       Date:  2014-05-15       Impact factor: 60.622

9.  p53-Pirh2 Complex Promotes Twist1 Degradation and Inhibits EMT.

Authors:  Yang Yang-Hartwich; Roslyn Tedja; Cai M Roberts; Jamie Goodner-Bingham; Carlos Cardenas; Marta Gurea; Natalia J Sumi; Ayesha B Alvero; Carlotta A Glackin; Gil Mor
Journal:  Mol Cancer Res       Date:  2018-08-21       Impact factor: 5.852

10.  MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/Akt-induced transformation.

Authors:  Eros Di Giorgio; Andrea Clocchiatti; Sara Piccinin; Andrea Sgorbissa; Giulia Viviani; Paolo Peruzzo; Salvatore Romeo; Sabrina Rossi; Angelo Paolo Dei Tos; Roberta Maestro; Claudio Brancolini
Journal:  Mol Cell Biol       Date:  2013-09-16       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.